DEA, Marijuana and administrative law judge

DEA Judge Cancels Marijuana Rescheduling Hearing Set For Next Week
A DEA judge cancelled a hearing to consider a proposal to reclassify marijuana amid allegations that officials at the agency improperly conferred with witnesses.
DEA Judge Cancels Marijuana Rescheduling Hearing Amid 'Disturbing' Allegations Of Improper Conduct
A federal judge delayed a pivotal hearing on the Biden administration's proposal to ease restrictions on marijuana, citing serious allegations of misconduct within the Drug Enforcement Administration (DEA).
DEA Judge Cancels Marijuana Rescheduling Hearings Amid Legal Challenges, Pushing Back Reform For At Least Three Months
The first hearings on the Biden administration’s marijuana rescheduling proposal that were set for next week have now been canceled following a legal challenge from pro-reform witnesses, a Drug Enforcement Administration (DEA) judge has ruled.
DEA judge postpones cannabis rescheduling hearings, Marijuana Moment reports
DEA Administrative Law Judge John Mulrooney has canceled the first hearings on the proposal to reschedule cannabis to a Schedule III drug after
DEA Judge Hits Pause on Cannabis Rescheduling Hearing
The judge’s order allows cannabis advocates, who argue that the DEA is “biased,” to continue their effort to have the DEA removed from the process.
Marijuana rescheduling judge blasts DEA for ‘unprecedented, astonishing’ behavior
DEA's refusal to comply with direct orders is “unprecedented and astonishing," says the judge overseeing the marijuana rescheduling hearing.
Cannabis Stocks Pull Back After DEA Postpones Rescheduling Hearings
AdvisorShares Pure US Cannabis, a popular exchange-traded fund tracking marijuana stocks, slid 3.6% to $3.44 on Thursday, hovering near an all-time low hit the day before. Shares of the biggest cannabis stocks, including Curaleaf Holdings, Green Thumb Industries and Trulieve Cannabis were down between 3% and 6%.
DEA marijuana rescheduling hearing cancelled following legal challenge
A Drug Enforcement Agency hearing that was scheduled for Jan. 21 to discuss the Biden Administration's plans to reschedule marijuana has been cancelled due to a legal challenge from those who want the rescheduling to go through.
Biggest Challenges for the Cannabis Industry in 2025
The U.S. cannabis industry faces five major hurdles holding back its growth, even as sales are projected to reach a record ...
Marijuana Moment1d
DEA Declines To Say Where It Stands On Marijuana Rescheduling In New Legal Filing Reacting To Claims It Conspired With Opponents
The Drug Enforcement Administration (DEA) is asking an agency judge to reject a request to have it removed from upcoming ...
Cannabis companies say DEA has closed mind against a less-dangerous pot ranking
Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under ...
Cannabis and Trump 2.0: 2025 and beyond
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...
Village Farms International Comments on Delayed Marijuana Rescheduling Process
Company views delay as imperative administrative step and symbolic win for industry against conflicted DEA –– Company condemns agency ...
NJBIZ1d
Could new Trump administration ease federal limits on cannabis?
While on the 2024 campaign trail, the president-elect voiced support for marijuana, “smart regulations” and ending “needless ...
What’s Changing in 2025 with Cannabis: A Look at Federal Legalization Efforts
In 2025, cannabis faces major changes with federal reclassification, easing regulations, increasing research, and opening ...